8158 Federal Register / Vol. 90, No. 15 / Friday, January 24, 2025 / Notices 

Controlled substance Drug code Schedule 

Phencyclidine ......................................................................................................................................................................... 7471 II 

4-Anilino-N-phenethyl-4-piperidine (ANPP) ........................................................................................................................... 8333 II 

Norfentanyl (N-phenyl-N-(piperidin-4-yl)propionamide) ......................................................................................................... 8366 II 

Phenylacetone ....................................................................................................................................................................... 8501 II 

1-Piperidinocyclohexanecarbonitrile ...................................................................................................................................... 8603 II 

Alphaprodine .......................................................................................................................................................................... 9010 II 

Anileridine .............................................................................................................................................................................. 9020 II 

Cocaine .................................................................................................................................................................................. 9041 II 

Codeine ................................................................................................................................................................................. 9050 II 

Etorphine HCl ........................................................................................................................................................................ 9059 II 

Dihydrocodeine ...................................................................................................................................................................... 9120 II 

Oxycodone ............................................................................................................................................................................. 9143 II 

Hydromorphone ..................................................................................................................................................................... 9150 II 

Diphenoxylate ........................................................................................................................................................................ 9170 II 

Ecgonine ................................................................................................................................................................................ 9180 II 

Ethylmorphine ........................................................................................................................................................................ 9190 II 

Hydrocodone ......................................................................................................................................................................... 9193 II 

Levomethorphan .................................................................................................................................................................... 9210 II 

Levorphanol ........................................................................................................................................................................... 9220 II 

Isomethadone ........................................................................................................................................................................ 9226 II 

Meperidine ............................................................................................................................................................................. 9230 II 

Meperidine intermediate-A .................................................................................................................................................... 9232 II 

Meperidine intermediate-B .................................................................................................................................................... 9233 II 

Meperidine intermediate-C .................................................................................................................................................... 9234 II 

Metazocine ............................................................................................................................................................................ 9240 II 

Oliceridine (N-[(3-methoxythiophen-2-yl)methyl] ({2-[(9R)-9-(pyridin-2-yl)-6-oxaspiro [4.5]decan-9-yl]ethyl{time})amine 

fumarate).

9245 II 

Methadone ............................................................................................................................................................................. 9250 II 

Methadone intermediate (4-cyano-2-dimethylamino-4,4-diphenylbutane ............................................................................. 9254 II 

Metopon ................................................................................................................................................................................. 9260 II 

Dextropropoxyphene, bulk (non-dosage forms) .................................................................................................................... 9273 II 

Morphine ................................................................................................................................................................................ 9300 II 

Oripavine ............................................................................................................................................................................... 9330 II 

Thebaine ................................................................................................................................................................................ 9333 II 

Dihydroetorphine ................................................................................................................................................................... 9334 II 

Levo-alphacetylmethadol ....................................................................................................................................................... 9648 II 

Poppy Straw .......................................................................................................................................................................... 9650 II 

Oxymorphone ........................................................................................................................................................................ 9652 II 

Noroxymorphone ................................................................................................................................................................... 9668 II 

Phenazocine .......................................................................................................................................................................... 9715 II 

Thiafentanil ............................................................................................................................................................................ 9729 II 

Piminodine ............................................................................................................................................................................. 9730 II 

Racemethorphan ................................................................................................................................................................... 9732 II 

Racemorphan ........................................................................................................................................................................ 9733 II 

Alfentanil ................................................................................................................................................................................ 9737 II 

Remifentanil ........................................................................................................................................................................... 9739 II 

Sufentanil ............................................................................................................................................................................... 9740 II 

Carfentanil ............................................................................................................................................................................. 9743 II 

Tapentadol ............................................................................................................................................................................. 9780 II 

Bezitramide ............................................................................................................................................................................ 9800 II 

Fentanyl ................................................................................................................................................................................. 9801 II 

Moramide-intermediate .......................................................................................................................................................... 9802 II 

The company plans to import the 

listed controlled substances for 

distribution for analytical testing 

purposes. No other activities for these 

drug codes are authorized for this 

registration. 

Approval of permit applications will 

occur only when the registrant’s 

business activity is consistent with what 

is authorized under 21 U.S.C. 952(a)(2). 

Authorization will not extend to the 

import of Food and Drug 

Administration-approved or nonapproved finished dosage forms for 

commercial sale. 

Matthew Strait, 

Deputy Assistant Administrator. 

[FR Doc. 2025–01707 Filed 1–23–25; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–1479] 

Bulk Manufacturer of Controlled 

Substances Application: Veranova, 

L.P. 

AGENCY: Drug Enforcement 

Administration, Justice. 

ACTION: Notice of application. 

SUMMARY: Veranova, L.P., has applied to 

be registered as a bulk manufacturer of 

basic class(es) of controlled 

substance(s). Refer to SUPPLEMENTARY


khammond on DSK9W7S144PROD with NOTICES
Federal Register / Vol. 90, No. 15 / Friday, January 24, 2025 / Notices 8159 

INFORMATION listed below for further 

drug information. 

DATES: Registered bulk manufacturers of 

the affected basic class(es), and 

applicants, therefore, may submit 

electronic comments on or objections to 

the issuance of the proposed registration 

on or before March 25, 2025. Such 

persons may also file a written request 

for a hearing on the application on or 

before March 25, 2025. 

ADDRESSES: The Drug Enforcement 

Administration requires that all 

comments be submitted electronically 

through the Federal eRulemaking Portal, 

which provides the ability to type short 

comments directly into the comment 

field on the web page or attach a file for 

lengthier comments. Please go to 

https://www.regulations.gov and follow 

the online instructions at that site for 

submitting comments. Upon submission 

of your comment, you will receive a 

Comment Tracking Number. Please be 

aware that submitted comments are not 

instantaneously available for public 

view on https://www.regulations.gov. If 

you have received a Comment Tracking 

Number, your comment has been 

successfully submitted and there is no 

need to resubmit the same comment. 

SUPPLEMENTARY INFORMATION: In 

accordance with 21 CFR 1301.33(a), this 

is notice that on November 25, 2024, 

Veranova, L.P., 25 Patton Road, 

Pharmaceutical Service, Devens, 

Massachusetts 01434–3803, applied to 

be registered as a bulk manufacturer of 

the following basic class(es) of 

controlled substance(s): 

Controlled substance Drug 

code Schedule 

Lysergic Acid 

Diethylamide.

7315 I 

Amphetamine .................. 1100 II 

Methylphenidate .............. 1724 II 

Nabilone .......................... 7379 II 

Hydrocodone ................... 9193 II 

Levorphanol ..................... 9220 II 

Thebaine .......................... 9333 II 

Alfentanil .......................... 9737 II 

Remifentanil ..................... 9739 II 

Sufentanil ......................... 9740 II 

The company plans to bulk 

manufacture the listed controlled 

substances in order to support the 

manufacturing and analytical testing 

activities at its other Drug Enforcement 

Administration-registered 

manufacturing facility. No other 

activities for these drug codes are 

authorized for this registration. 

Matthew Strait, 

Deputy Assistant Administrator. 

[FR Doc. 2025–01711 Filed 1–23–25; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF JUSTICE 

Notice of Lodging of Proposed 

Consent Decree 

In accordance with Departmental 

Policy, 28 CFR 50.7, notice is hereby 

given that a proposed Consent Decree in 

United States v. Elmore Sand & Gravel, 

Inc., Case No. 2:25–cv–60, was lodged 

with the United States District Court for 

the Middle District of Alabama on 

January 17, 2025. 

This proposed Consent Decree 

concerns a complaint filed by the 

United States against Defendant Elmore 

Sand & Gravel, Inc., pursuant to Section 

309 of the Clean Water Act, 33 U.S.C. 

1319, to obtain injunctive and other 

appropriate relief from the Defendant 

for violating the Clean Water Act by 

discharging pollutants without 

authorization into waters of the United 

States. The proposed Consent Decree 

resolves these allegations by requiring 

the Defendant to perform mandatory 

injunctive relief (including stabilization, 

remediation, wastewater management, 

enhancement, mitigation, and 

preservation measures) and subjects the 

Defendant to other appropriate relief. 

The Department of Justice will accept 

written comments relating to this 

proposed Consent Decree for thirty (30) 

days from the date of publication of this 

Notice. Please address comments by 

mail to Andrew Doyle and Martin 

McDermott, United States Department 

of Justice, Environment and Natural 

Resources Division, Environmental 

Defense Section, Post Office Box 7611, 

Washington, DC 20044, or by email to 

pubcomment_eds.enrd@usdoj.gov and 

refer to United States v. Elmore Sand & 

Gravel, Inc., DJ No. 90–5–1–1–21374. 

The proposed Consent Decree may be 

examined at the Clerk’s Office, United 

States District Court for the Middle 

District of Alabama, One Church Street, 

Montgomery, AL 36104. In addition, the 

proposed Consent Decree may be 

examined electronically at https://

www.justice.gov/enrd/consent-decrees. 

Cherie Rogers, 

Assistant Section Chief, Environmental 

Defense Section, Environment and Natural 

Resources Division, United States Department 

of Justice. 

[FR Doc. 2025–01668 Filed 1–23–25; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF JUSTICE 

Notice of Lodging of Proposed 

Consent Decree Under the 

Comprehensive Environmental 

Response, Compensation, and Liability 

Act 

On January, 17, 2025, the Department 

of Justice lodged a proposed Consent 

Decree with the United States District 

Court for the Northern District of 

California, in the lawsuit entitled 

United States of America, ex. Rel., 

Arthur R. Jahr, III et al., Anthony Smith 

& Donald K. Wadsworth et al. v. Tetra 

Tech EC Inc, Civil Action No. 3:13–cv– 

3835 JD, pertaining to the Hunters Point 

Naval Shipyard Superfund Site in San 

Francisco, California. 

The Consent Decree resolves the Fifth 

Cause of Action set forth in the United 

States’ Second Amended Complaint 

filed in the above referenced matter 

(‘‘CERCLA Claim’’). The CERCLA Claim 

asserts that response action contractor, 

Tetra Tech EC (‘‘TtEC’’), is liable under 

Section 107(a) of CERCLA as both an 

operator of the facility at the time of the 

disposal of a hazardous substance, and 

as a transporter for disposal of a 

hazardous substance at the site. TtEC 

signed the consent decree. TtEC will 

pay $40 million in response costs. In 

return, the United States agrees not to 

sue TtEC under sections 106 and 107 of 

CERCLA. The Consent Decree also 

resolves TtEC’s counterclaim against 

Navy pursuant to Section 113(f) of 

CERCLA seeking contribution, equitable 

allocation of response costs incurred at 

the site, equitable contribution, 

equitable indemnity and declaratory 

relief. 

The publication of this notice opens 

a period for public comment on the 

Consent Decree. Comments should be 

addressed to the Assistant Attorney 

General, Environment and Natural 

Resources Division, and should refer to 

United States of America, ex. Rel., 

Arthur R. Jahr, III et al., Anthony Smith 

& Donald K. Wadsworth et al. v. Tetra 

Tech EC Inc, D.J. Ref. No. 90–11–3– 

12345. All comments must be submitted 

no later than thirty (30) days after the 

publication date of this notice. 

Comments may be submitted either by 

email or by mail: 

To submit 

comments: Send them to: 

By email ....... pubcomment-ees.enrd@

usdoj.gov. 

By mail ......... Assistant Attorney General, 

U.S. DOJ—ENRD, P.O. 

Box 7611, Washington, DC 

20044–7611. 


khammond on DSK9W7S144PROD with NOTICES